These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 6778385)

  • 1. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
    Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
    Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
    Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
    Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In vitro activity of rosoxacin (Win 35 213) against Neisseria gonorrhoeae (author's transl)].
    Braveny I; Machka K
    Arzneimittelforschung; 1980; 30(9):1476-8. PubMed ID: 6779824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
    Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
    Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of lomefloxacin against Chlamydia trachomatis, Neisseria gonorrhoeae, Haemophilus ducreyi, Mycoplasma hominis, and Ureaplasma urealyticum.
    Hoban D; DeGagne P; Witwicki E
    Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):83S-86S. PubMed ID: 2507222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative in vitro effect of 7 quinolones on Ureaplasma urealyticum].
    Cantet P; Renaudin H; Quentin C; Bebear C
    Pathol Biol (Paris); 1983 Jun; 31(6):501-3. PubMed ID: 6224125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activities of lomefloxacin, tetracycline, penicillin, spectinomycin, and ceftriaxone against Neisseria gonorrhoeae and Chlamydia trachomatis.
    Talbot H; Romanowski B
    Antimicrob Agents Chemother; 1989 Dec; 33(12):2049-51. PubMed ID: 2533473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activities of new quinoline derivatives against genital pathogens.
    Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
    Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the disease.
    Hawkins DA; Taylor-Robinson D; Evans RT; Furr PM; Harris JR
    Genitourin Med; 1985 Feb; 61(1):51-5. PubMed ID: 3910541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro antigonococcal activity of rosoxacin (WIN 35213).
    Warren CA; Shannon KP; Phillips I
    Br J Vener Dis; 1981 Feb; 57(1):33-5. PubMed ID: 6781706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
    Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
    Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of rosoxacin, fosfomycin, cefotiam, and spectinomycin on beta-lactamase producing Neisseria gonorrhoeae.
    Dickgiesser N; Kuntz P
    Br J Vener Dis; 1984 Jun; 60(3):154-6. PubMed ID: 6329404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
    Peeters M; Van Dyck E; Piot P
    Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vitro activity of Mk-0366 and other selected oral antimicrobial agents against Neisseria gonorrhoeae.
    Khan MY; Siddiqui Y; Gruninger RP
    Antimicrob Agents Chemother; 1981 Aug; 20(2):265-6. PubMed ID: 6456692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of gonococci to rosoxacin compared with that of penicillin, cefuroxime and tetracycline.
    Seth AD
    J Antimicrob Chemother; 1981 Apr; 7(4):331-4. PubMed ID: 6788746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
    Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
    Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
    Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
    Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of Ureaplasma urealyticum to ten chemotherapeutic agents.
    Sobetzko R; Hartmann AA; Elsner P
    Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Aug; 269(2):245-50. PubMed ID: 2973712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial sensitivity of Neisseria gonorrhoeae to spectinomycin & rosoxacin.
    Bhujwala RA; Bhargava NC; Biswas TD; Narain S; Pandhi RK
    Indian J Med Res; 1987 Dec; 86():702-6. PubMed ID: 2967246
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of uncomplicated gonorrhea with rosoxacin.
    Handsfield HH; Judson FN; Holmes KK
    Antimicrob Agents Chemother; 1981 Nov; 20(5):625-9. PubMed ID: 6798924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.